Loading interface...

Aluvia Tablet

Manufactured byABBOTT HEALTHCARE PVT LTD
ContainsLopinavir (200 mg) + Ritonavir (50 mg)
Description

Aluvia Tablet is a combination medicine used to treat human immunodeficiency virus (HIV). This medicine is not a cure for HIV. It only prevents the virus from multiplying in your body. Monitoring of liver function and blood glucose levels is necessary while receiving this medicine.

How will this medicine affect me?

Consult top doctors online and get an answer now
Chat now
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Book now

Side effects

Major & minor side effects for Aluvia Tablet

  • Diarrhea
  • Vomiting
  • Nausea
  • Abdominal pain
  • Constipation
  • Indigestion
  • Rash
  • Itching
  • Blurred vision
  • Fever
  • Dizziness
  • Feeling of warmth or heat
  • Redness of the skin especially on the face and neck
  • Headache
  • Sweating
  • Weight loss
  • Confusion
  • Acid or sour stomach
  • Change in sense of taste
  • Sleepiness or unusual drowsiness
  • Mood or mental changes
  • Tender, swollen glands in the neck

Uses of Aluvia Tablet

What is it prescribed for?

  • HIV infection
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is recommended for use in breastfeeding women only in life-threatening conditions. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to lopinavir, ritonavir, or any other inactive ingredients present along with these medicines.

CYP3A4 inhibitors, inducers, and CYP3A4-dependent drugs

This medicine is not recommended for use in patients receiving medicines which are highly dependent on CYP3A for their clearance as well as strong CYP3A inducers and inhibitors due to the increased risk of serious and life-threatening adverse effects.

Severe Hepatic impairment

This medicine is not recommended for use in patients suffering from a severe impairment of liver function due to the increased risk of worsening of the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is recommended for use in breastfeeding women only in life-threatening conditions. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.
General warnings

Altered blood glucose levels

This medicine may alter blood glucose levels in some patients. This risk is especially higher in patients with a history of diabetes mellitus. Report any unusual symptoms to the doctor immediately. Close monitoring of blood glucose levels, appropriate dose adjustments, or replacement with a suitable alternative may be necessary in some cases based on the clinical condition of the patient.

Hepatotoxicity

This medicine should be used with caution in patients with a history of liver diseases and active liver diseases due to the increased risk of worsening of the patient's condition. Report any unusual symptoms to the doctor immediately. Monitoring of liver function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

Bleeding disorder

This medicine should be used with caution in patients with a history of bleeding disorders such as Hemophilia A or Hemophilia B due to an increase in the risk of excessive bleeding. Report any unusual symptoms to the doctor on priority. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

Fat Redistribution

This medicine may cause fat gain or fat loss from the body. This may result in peripheral wasting, facial wasting, breast enlargement, and Cushingoid appearance. Close monitoring of body weight and body fat distribution is necessary while receiving this medicine. Any changes in the body should be informed to the doctor on priority. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Pancreatitis

This medicine should be used with caution due to an increase in the risk of pancreatitis. Report any unusual symptoms to the doctor on priority. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

Once daily regimen

This dosage regimen is not recommended for use: 1. In patients with three or more lopinavir resistance-associated substitutions. 2. In a combination with efavirenz, nevirapine, or nelfinavir. 3. In patients receiving carbamazepine, phenobarbital, or phenytoin. 4. In pregnant women. 5. In patients less than 18 years of age.

Use in Pediatrics

This medicine should be used with extreme caution in patients less than 18 years of age and only under the supervision of your doctor.

Missed Dose

Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Carbamazepine

Erythromycin

Fluoxetine

Midazolam

Rosuvastatin

Alprazolam

Atorvastatin

Acarbose

abemaciclib

Disease interactions

Liver Disease

This medicine should be used with extreme caution in patients with a history of liver diseases since it may increase the risk of worsening of the patient's condition. Monitoring of the liver function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Diabetes Mellitus

This medicine should be used with extreme caution in patients suffering from diabetes mellitus due to the increased risk of altered blood glucose levels. Blood glucose levels should be monitored closely during treatment with this medicine. Report any symptoms such as frequency of urination, excessive thirst, etc. to the doctor immediately. If necessary, the dose of the antidiabetic agents should be adjusted based on the clinical condition.

Cardiovascular disease

This medicine should be used with caution in patients with a history of cardiovascular diseases due to the increased risk of worsening of the patient's condition. Close monitoring of heart function is advised during treatment with this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Hemophilia

This medicine should be used with caution in patients suffering from hemophilia due to the increased risk of worsening of the patient's condition. You may require a dose adjustment and more frequent clinical monitoring to safely use this medicine. An alternative treatment option may be considered based on the clinical condition of the patient.
Food interactions
Information not available.
Lab interactions
Information not available.
Take this medicine with or without food, as directed by your doctor. Do not take in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Complete the course of treatment to prevent the spread of the infection. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
It works by stopping the human immunodeficiency virus (HIV) from multiplying. This helps in reducing the chances of development of acquired immunodeficiency syndrome (AIDS) and other HIV-related illnesses.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Protease inhibitors

Schedule

Schedule H

[Internet]. Rxabbvie.com. 2018 [cited 9 August 2018]. Available from:

https://www.rxabbvie.com/pdf/kaletratabpi.pdf

[Internet]. AIDSinfo. 2018 [cited 9 August 2018]. Available from:

https://aidsinfo.nih.gov/drugs/316/kaletra/31/professional

Kaletra 200 mg/50 mg film-coated tablets - Summary of Product Characteristics (SmPC) - (eMC) [Internet]. Medicines.org.uk. 2018 [cited 9 August 2018]. Available from:

https://www.medicines.org.uk/emc/product/221/smpc#

Lopinavir and Ritonavir: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2018 [cited 9 August 2018]. Available from:

https://medlineplus.gov/druginfo/meds/a602015.html
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 6 Sep 2018

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.